CG
LGND icon

Colony Group’s Ligand Pharmaceuticals LGND Stock Holding History

Colony Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,579
Closed -$1.21M – 729
2019
Q4 		$1.21M Sell
18,579
-2,507
-12% -$168K 0.03% 374
2019
Q3 		$1.31M Sell
21,086
-2,071
-9% -$130K 0.04% 328
2019
Q2 		$1.65M Buy
23,157
+21
+0.1% +$1.55K 0.05% 305
2019
Q1 		$1.81M Buy
23,136
+1,640
+8% +$124K 0.08% 217
2018
Q4 		$1.82M Buy
21,496
+1,802
+9% +$192K 0.09% 193
2018
Q3 		$3.37M Sell
19,694
-424
-2% -$63.9K 0.17% 125
2018
Q2 		$2.6M Sell
20,118
-9,733
-33% -$1.09M 0.14% 151
2018
Q1 		$3.08M Sell
29,851
-478
-2% -$47.3K 0.17% 129
2017
Q4 		$2.59M Sell
30,329
-2,789
-8% -$242K 0.16% 134
2017
Q3 		$2.81M Sell
33,118
-1,986
-6% -$157K 0.19% 110
2017
Q2 		$2.66M Sell
35,104
-409
-1% -$28.6K 0.19% 114
2017
Q1 		$2.35M Sell
35,513
-697
-2% -$45.9K 0.22% 107
2016
Q4 		$2.29M Buy
36,210
+146
+0.4% +$9.21K 0.25% 98
2016
Q3 		$2.3M Sell
36,064
-1,090
-3% -$80K 0.26% 83
2016
Q2 		$2.76M Sell
37,154
-933
-2% -$69.2K 0.3% 69
2016
Q1 		$2.54M Sell
38,087
-96
-0.3% -$5.83K 0.29% 70
2015
Q4 		$2.58M Buy
38,183
+368
+1% +$22.7K 0.24% 97
2015
Q3 		$2.02M Buy
+37,815
New +$2.29M 0.23% 98

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Colony Group's LGND Position: Q1 2020 in Review

Colony Group sold out of Ligand Pharmaceuticals (LGND) in Q1 2020, closing a stake of 18,579 shares — an estimated $1.21M sold.

Colony Group first reported a position in LGND in Q3 2015 and held it in 18 quarters. The position peaked at $3.37M in Q3 2018. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2020.

  • Colony Group reported no remaining Ligand Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Colony Group sold 18,579 Ligand Pharmaceuticals shares in Q1 2020, an estimated $1.21M.
  • Colony Group first reported a position in Ligand Pharmaceuticals in Q3 2015 and held it in 18 quarters.
  • Colony Group's Ligand Pharmaceuticals position peaked at $3.37M in Q3 2018.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2020.

Based on Colony Group's 13F filing for Q1 2020, filed 18 May 2020.